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bjectives We hypothesized that X-ray fused with magnetic resonance imaging (XFM) roadmaps
ight permit direct antegrade crossing and delivery of a ventricular septal defect (VSD) closure de-
ice and thereby reduce procedure time and radiation exposure.
ackground Percutaneous device closure of membranous VSD is cumbersome and time-consuming.
he procedure requires crossing the defect retrograde, snaring and exteriorizing a guidewire to form
n arteriovenous loop, then delivering antegrade a sheath and closure device.
ethods Magnetic resonance imaging roadmaps of cardiac structures were obtained from minia-
ure swine with spontaneous VSD and registered with live X-ray using external ﬁducial markers. We
ompared antegrade XFM-guided VSD crossing with conventional retrograde X-ray–guided crossing
or repair.
esults Antegrade XFM crossing was successful in all animals. Compared with retrograde X-ray,
ntegrade XFM was associated with shorter time to crossing (167  103 s vs. 284  61 s; p 
.025), shorter time to sheath delivery (71  32 s vs. 366  145 s; p  0.001), shorter ﬂuoroscopy
ime (158  95 s vs. 390  137 s; p  0.003), and reduced radiation dose–area product (2,394 
,522 mG·m2 vs. 4,865  1,759 mG·m2; p  0.016).
onclusions XFM facilitates antegrade access to membranous VSD from the right ventricle in swine.
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225ercutaneous closure of membranous ventricular septal defect
VSD) is now feasible using commercial devices (1,2). Con-
entional percutaneous techniques are cumbersome and re-
uire multiple steps—retrograde defect crossing, snare-
ecovery of a guidewire, formation of an arteriovenous
uidewire loop, and placement of an antegrade delivery
heath—all before antegrade delivery of the occluder device (3).
oreover, sheath access may be lost during device delivery and
he crossing steps must be repeated. The procedure is techni-
ally challenging, mainly because imaging limitations preclude
irect antegrade access to the VSD from the right ventricle. As
result, conventional transcatheter VSD closure typically
equires prolonged exposure to ionizing radiation.
To enhance image guidance, we combine magnetic res-
nance imaging (MRI) roadmaps with live X-ray (X-ray
used with magnetic resonance imaging [XFM]), based on
xternal fiducial markers (4,5). We overlay MRI-derived
eatures, such as VSD location and endoventricular con-
ours, to position and deliver an asymmetric nitinol occluder
evice in swine.
We hypothesize that XFM enables direct antegrade
rossing, simplifies and shortens procedure conduct, and
educes radiation exposure during closure in animals with
ongenital membranous VSD.
ethods
nimal procedures. Animal procedures were approved by
he National Heart Lung and Blood Institute Animal Care
nd Use Committee. Fourteen Yucatan miniature swine (29
o 67 kg) with spontaneous VSD (Sinclair Research Center,
olumbia, Missouri) were anesthetized with atropine, bu-
orphanol, ketamine, and xylazine, and then maintained on
soflurane and mechanical ventilation. Four additional VSD
iniswine were used during technical computer develop-
ent and were not analyzed further.
Interventional procedures were conducted using percuta-
eous transfemoral artery and vein access. Left-to-right
hunts were measured by oximetry and MRI. The VSD
imensions were measured using both MRI and radiocon-
rast angiography with calibrated catheters.
RI and XFM registration. Experiments were conducted in a
ual X-ray and MRI intervention suite (6). Sixteen fiducial
arkers conspicuous under both X-ray and MRI (Beekley
orp., Bristol, Connecticut), were secured on the thorax.
nd-expiratory roadmaps were obtained using MRI at 1.5-T
Espree, Siemens, Erlangen, Germany) and a standard
-channel phased array surface coil. Typical electrocardiogram-
ated segmented steady-state free precession (SSFP) acquisi-
ion parameters were: repetition time/echo time: 3/1.5 ms; flip
ngle: 80°; bandwidth: 930 Hz/pixel; 1.8  1.8  6 mm
oxels. Typical “black-blood” turbo spin echo images used:
epetition time/echo time: 700/34 ms; bandwidth: 292 Hz/ Jixel; 1.4  2.2  3 to 6 mm voxels. Typical phase-contrast
radient echo acquisition parameters were: repetition time/
cho time: 6.3/2.9 ms; flip angle: 30°; bandwidth: 434 Hz/
ixel; 1.4  2.5  6 mm voxels. The VSD dimensions were
easured on representative long-axis SSFP and turbo spin
cho MRI images.
After MRI, the animals were transferred to a single-plane
-ray system (Axiom Artis FC, Siemens) using a mechanized
idirectional transport table (Miyabe, Siemens). Single-phase
R images were registered to the live X-ray acquisitions (4).
riefly, external fiducial markers, conspicuous under both
-ray and MRI, were matched and the 2 coordinate systems
ere aligned with rigid-body registration algorithms using
ustom image processing software written in MATLAB
Mathworks, Cambridge, Massachusetts). The MRI regions
f interest included contours of the VSD, ventricular cavities,
utflow tracts, aortic valve, and aortic root (Fig. 1). These were
egmented manually while the animals were transferred from
RI to X-ray and then presented to the operator as a static
mage overlay on real-time X-ray fluoroscopic images. Cathe-
er procedures were conducted only in the X-ray lab.
Target registration error was
efined as the 2-dimensional dis-
ance between VSD center-of-
ass on X-ray cineangiography
nd SSFP MRI during systole at
nd-expiration. Although the
efect could easily be visualized
nder MRI throughout the car-
iac cycle, in cineangiography it
as best identified by the jet of
ontrast ejected across the defect
uring systole.
SD closure procedures. DEFECT CROSSING: CONVEN-
IONAL, RETROGRADE TECHNIQUE. Figure 2A shows the
tandard crossing technique that we used (3). We first
cquired a radiocontrast ventriculography roadmap in a
ranial and left anterior oblique projection. We crossed the
SD using retrograde transaortic, braided 6-F coronary
ngiographic catheters from the left ventricle and positioned
oft guidewires into a distal pulmonary artery branch. We
aptured and exteriorized the guidewire using a transfemo-
al venous snare (Amplatz Gooseneck, ev3 Inc., Plymouth,
innesota) to form an arteriovenous loop.
To complete the procedure, a delivery sheath (Torque-
iew, AGA Medical, Plymouth, Minnesota) is advanced
ver this loop from the venous side across the VSD. We did
ot close the defects until techniques were compared.
EFECT CROSSING: INVESTIGATIONAL, ANTEGRADE TECH-
IQUE. We crossed antegrade using XFM from the right
entricle into the left ventricle using pre-formed diagnostic
atheters and 0.035-inch hydrophilic guidewires (angled
lidewire, Terumo Medical Corporation, Somerset, New
Abbreviations
and Acronyms
MRI  magnetic resonance
imaging
SSFP  steady state free
precession
XFM  X-ray fused with
magnetic resonance imaging
VSD  ventricular septal
defectersey) (Fig. 2B).
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226Before closure, with the catheter in the descending aorta,
he hydrophilic wire was exchanged for a rigid 0.035-inch
uidewire (Supra-core, Abbott, Santa Clara, California).
ERCUTANEOUS MEMBRANOUS VSD DEVICE CLOSURE. The
elivery sheath was advanced across the defect and into the
escending aorta. Then the rigid wire was replaced with a
exible guidewire (Noodle, AGA Medical) to redirect the
heath toward the left ventricular apex.
The Amplatzer Membranous VSD Occluder was sized
ccording to manufacturer instructions (1 to 2 mm larger
han angiographic VSD diameter). The asymmetric left
entricular disk was oriented based on the XFM represen-
ation of the apex. Positioning was confirmed by radiocon-
rast ventriculography and aortography before device release
nd by MRI and necropsy afterward.
xperimental design. In an initial training phase (4 ani-
als), we tested feasibility of XFM-guided antegrade VSD
Figure 1. MRI-Derived Contours
(A) Long-axis 3-chamber SSFP MRI used to contour VSD (white arrow) and ao
left (blue) ventricular endocardial surfaces and left ventricular epicardial surfac
leaﬂets (black). (D) Surface rendering of MRI-derived contours. The yellow do
aorta; ENDO  endocardial surface; EPI  epicardial surface; LV  left ventricl
RV  right ventricle; VSD  ventricular septal defect.rossing. XIn the experimental phase (10 animals), we recorded
rocedure times and radiation exposure. We tested each
pproach 3 to 4 times in each animal in random order
conventional retrograde followed by investigational ante-
rade or investigational followed by conventional). First, we
ompared antegrade VSD guidewire crossing under X-ray
r XFM guidance using identical catheter technique (3
nimals). Next, we compared antegrade XFM guidance
ith conventional retrograde X-ray guidance for VSD
uidewire crossing and sheath delivery (7 animals). To
reserve defect anatomy for crossing comparisons, relatively
ulky (9-F) delivery sheaths were not advanced across the
efect until all attempts were completed. Animals under-
ent cardiac MRI before euthanasia and necropsy. All
rocedures were performed by a single operator. To mini-
ize “operator memory” effects, different image displays
monitors) were used for XFM-guided and conventional
ot (black arrow). (B) Short-axis SSFP MRI used to contour right (yellow) and
en). (C) Short-axis SSFP MRI used to contour aortic valve annulus (blue) and
ates the left ventricular apex. See accompanying Online Video 3. AO 
 magnetic resonance imaging; SSFP  steady state free precession MRI;rtic ro
e (gre
t indic
e; MRI-ray-guided procedures.
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227The VSD crossing time is defined as the time the femoral
heath is entered until the guidewire is in the distal
ulmonary artery (retrograde) or descending aorta (ante-
rade). The sheath delivery time begins after the VSD is
rossed and ends when the arteriovenous loop is formed
retrograde) or the descending aorta is entered with the rigid
uidewire (antegrade). Total fluoroscopy time and radiation
xposure encompass VSD crossing and sheath delivery.
ata analysis. For each animal we averaged 3 to 4 measure-
ents, so as not to exaggerate the statistical degrees of
reedom. Results are expressed as mean  SD. Component
rocedure times and radiation exposure were compared
sing 2-tailed Student t tests, adjusted for unequal variances
hen appropriate (Excel, Microsoft, Redmond, Washing-
on). Results were considered to be statistically significant at
Figure 2. Schematic Depictions of Conventional and Investigational Proced
(A) Conventional retrograde X-ray technique. (1) Retrograde, transaortic access
tricle across the VSD. (3) A transfemoral venous snare retrieves the transaortic
provide a rail to deliver the rigid VSD delivery sheath. (5) The delivery sheath
and released. (B) Investigational XFM-guided antegrade technique. (1) With en
tricle through the VSD into the left ventricle and descending aorta. (2) The de
positioned and released. The XFM technique has fewer steps. Courtesy of Lydi
resonance imaging; other abbreviations as in Figure 1.value of p  0.05. cesults
natomic and physiologic ﬁndings. Congenital membra-
ous VSDs were evident on MRI and radiocontrast ven-
riculography. Defect diameter ranged from 2.5 to 8 mm.
ulmonary-systemic flow ratios ranged from 1.3 to 3.4 and
ere similar by oximetry and velocity-encoded MRI. Older
nimals tended to have smaller VSDs and aneurysmal
ricuspid tissue encroaching on the VSD.
rocedural details and complications. In these experiments,
1 additional fluoroscopy frames were performed solely for
egistration with MRI, adding a total of 0.030 mG·m2
ncremental radiation, or 1% of the total average radiation
xposure for animal.
During technical development, we found that pre-formed
echnique
e left ventricle. (2) A guidewire crosses retrograde from the left to right ven-
wire from the pulmonary artery. (4) An arteriovenous loop is exteriorized to
itioned antegrade across the VSD. (6) The VSD occlusion device is positioned
d imaging guidance, the guidewire is passed antegrade from the right ven-
sheath is positioned in the left ventricle. (3) The VSD occlusion device is
k, NIH Medical Arts and Photography Branch. XFM  X-ray guided magneticure T
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228iams Right, 6-F Expo, Boston Scientific, Natick, Massa-
husetts) simplified antegrade crossing compared with
ingle-plane curve shapes (Judkins right, right coronary
ypass). We used Williams Right shaped catheters thereaf-
er for antegrade crossing in the experimental phase.
The XFM registration was unavailable in 4 additional
echnical development experiments because of computer
alfunction. In these, all VSD crossing attempts were
nsuccessful despite 15 min of fluoroscopy and the proce-
ures were aborted.
There were no procedural complications including con-
uction or rhythm abnormalities, atrioventricular or semi-
unar valvular regurgitation, or pericardial effusion. More-
ver there was no sheath kinking or device embolization.
omparison of image-guidance techniques. Antegrade
FM-guided crossing was successful in all 14 animals at-
empted (Online Video 1). Figure 3 demonstrates the utility of
n MRI roadmap to provide a target for antegrade VSD
rossing compared with X-ray alone. The system automatically
pdated MRI roadmaps “in real time” when table position,
-ray gantry angulation, magnification, and X-ray source
mage distance were changed. This was helpful, for example, to
onfirm guidewire, sheath, and device position.
We found that “blind” antegrade X-ray crossing generally
equired positioning the catheter near the expected VSD
ocation and probing using a guidewire. By comparison,
FM generally permitted direct entry into the VSD with
he catheter.
Compared with retrograde X-ray, antegrade XFM was
Figure 3. X-Ray Fluoroscopic Landmarks Compared With XFM Roadmaps
(A) X-ray depicts the ventricular septal defect (white arrow) only during radio
sentative image of direct antegrade VSD guidewire crossing using XFM guidan
(yellow), the left ventricular epicardial contour (green), the left ventricular end
(red), and aortic valve (blue annulus with black leaﬂets). The guidewire (wh
3-dimensional curve right coronary artery catheter. The MRI-derived contours a
Online Video 1. Abbreviations as in Figures 1 and 2.ssociated with shorter time to crossing, shorter time toheath delivery, shorter fluoroscopy time, and reduced
adiation dose-area product (Table 1, Fig. 4A).
Likewise, XFM-guided antegrade VSD crossing was
-fold faster than X-ray guided antegrade technique (itself
ot a conventional standard; XFM 69  43 s vs. antegrade
-ray 366  179 s; p  0.049).
The XFM-guided device closure of VSD appropriately
ttenuated left-to-right flow across the defect without
ncroaching on the aortic valve leaflets (Fig. 4B, Online
ideo 2). Whether XFM or conventional X-ray technique
as used first did not affect procedural time or radiation
xposure.
arget registration error. Target registration error between
enter points on cineangiography and SSFP MRI derived
SD contours was 4.9  2.3 mm.
ecropsy. Explanted hearts from 5 successive animals indi-
ated appropriate device positioning, appropriate device
ngular orientation relative to the aortic valve, no encroach-
st injections. Black arrows indicate the external ﬁducial beads. (B) A repre-
e XFM roadmap elements include the right ventricular endocardial contour
ial contour (blue), the VSD tract (red outline and black arrow), aortic root
ow) is delivered across the VSD and into the aorta using a right-handed
automatically when the X-ray system is repositioned. See accompanying
Table 1. A Comparison of Antegrade XFM With Conventional Retrograde
X-Ray Guided Transcatheter VSD Repair
Antegrade
XFM
Conventional
Retrograde
X-Ray p Value
VSD crossing, s 167 103 284 61 0.025
Sheath positioning, s 71 32 366 145 0.001
Total ﬂuoroscopy, s 158 95 390 137 0.003
Radiation dose–area product, mG·m2 2,394 1,522 4,865 1,759 0.016contra
ce. Th
ocard
ite arr
djustVSD ventricular septal defect; XFM X-ray fused with magnetic resonance imaging.
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229ent on aortic valve leaflets, and freedom from tricuspid
alve entrapment.
iscussion
ranscatheter closure of membranous VSD is technically
hallenging (7), primarily because contemporary interven-
ional imaging tools delineate anatomy poorly. Fluoroscopy
ffords no landmarks to navigate across the VSD. As a
esult, direct antegrade access to the VSD is generally
voided. In this experiment, XFM enhances image guidance
ufficiently to enable direct antegrade crossing and repair. It
educes the number of procedure steps, reduces procedure
imes, fluoroscopy, and radiation exposure. XFM continu-
usly depicts the relationship between structures and their
-ray projection despite changes in gantry angulation and
able position (Online Video 3). The XFM roadmaps also
nhance subjective operator confidence by delineating critical
ntracardiac structures and spatial relationships.
onventional versus antegrade repair. Right ventricular tra-
eculation (8), aneurysmal tricuspid valve tissue (9), and
elated flow perturbations interfere with antegrade percuta-
eous VSD crossing and closure. XFM mitigates these
natomic and functional obstacles. The VSD target dis-
layed on XFM permits the operator to avoid chordal and
rabecular entrapment. XFM allowed the operator directly
o enter the VSD with the catheter. Conventional X-ray
enerally required the operator to find the VSD with a
robing guidewire in a process that might entrap chordae.
XFM simplifies VSD closure into a direct antegrade
Figure 4. XFM Positioning of Delivery Sheath and VSD Occluder Deploymen
(A) Antegrade sheath delivery guided by XFM. The sheath is directed toward t
right (yellow) and left (blue) ventricular endocardial contours, left ventricular
(bright red). (B) Conﬁrmatory XFM radiocontrast ventriculography before relea
occluder (white arrow), VSD tract (bright red contour), right (yellow) and lef
aortic valve (dark blue), and aortic root (dark red). See accompanying Onlinerocedure. By contrast, the conventional retrograde ap- troach requires cumbersome crossing from left to right,
naring and then exteriorizing the guidewire to form an
rteriovenous loop, followed by positioning and delivering
he closure device under fluoroscopic and echocardiographic
uidance.
Faster crossing and sheath delivery is particularly helpful
uring procedures complicated by inadvertent loss of sheath
osition, in which case these steps must be repeated. Direct
ntegrade crossing may also be germane to treatment of
uscular and post-infarction VSD where defects are often
ultiple (10). That said, direct retrograde repair of muscular
SD has been reported (11).
afety. Ionizing radiation is associated with a spectrum of
alignancy (12). Children are especially sensitive to radiation
xposure and may survive longer to experience radiation-
ssociated toxicity. Children with congenital cardiovascular
isease often require multiple exposures to medical radiation.
ndreassi et al. (13) found evidence of chromosomal damage
n patients with congenital heart disease exposed to radiation.
he U.S. National Research Council considers cancer risk
roportional to exposure even at the lowest levels (14). In this
tudy, XFM halved radiation exposure.
Safe percutaneous VSD closure requires particular attention
o critical structures such as the aortic valve (15). Subjectively,
etailed soft tissue information from MRI enhances operator
onfidence navigating the complex spatial relationships among
ital intracardiac structures. Indeed, when XFM was techni-
ally unavailable, our antegrade approach was not readily
ccomplished. XFM also facilitated appropriate orientation of
t ventricular apex using a ﬂexible guidewire. The XFM roadmap includes
dial contour (green), aortic annulus (blue), aortic root (red), and VSD tract
VSD occluder device deployed in position. Features include the VSD
e) ventricular endocardial and left ventricular epicardial (green) contours,
2. Abbreviations as in Figures 1 and 2.t
he lef
epicar
se of
t (blu
Videohe asymmetric occluder device with regard to the aortic valve
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230nd cardiac apex, although we offer no quantitative supporting
ata.
tudy limitations. We did not use transesophageal echocar-
iography or biplane fluoroscopy, which are typical adjuncts
o conventional retrograde VSD repair. In our clinical
xperience, transesophageal and intracardiac echocardiogra-
hy have value in selecting, positioning, and assessing
losure devices, but have limited value in actual defect
rossing, the procedure tested here. Biplane fluoroscopy
ight be expected to shorten retrograde crossing times
lightly at the expense of additional radiation exposure. We
id not compare XFM with newer 3-dimensional surface or
ransesophageal echocardiography (16). Three-dimensional
arget registration error is expected to be greater than the
-dimensional measurements we report. These experiments
ere conducted in swine with congenital VSD and sur-
ounding aneurysmal tricuspid valve tissue; humans have
imilar anatomy (17).
uture steps. We measured a target registration error of
.9 2.3 mm without correction for cardiac and respiratory
otion. With further technical development, XFM systems
ight compensate for respiratory motion; automatically
repare multiphase MRI roadmaps for electrocardiography-
ynchronized overlay; register based on intrinsic fiducial
andmarks rather than external beads; and incorporate
dditional imaging modalities such as ultrasound. That said,
arly generation XFM has been tested in humans (5,18) and
s now suitable for clinical application in treatment of
embranous and single or multiple muscular VSDs. Clin-
cal end points might include technical success and morbid-
ty, radiation exposure, and long-term outcomes.
onclusions
he XFM procedure enhances the familiar X-ray environ-
ent with superior MRI soft tissue information to facilitate
omplex interventions. In this study, XFM simplified and
hortened the procedure and reduced radiation exposure.
any congenital structural anomalies, with similarly com-
lex intracardiac 3-dimensional anatomical spatial relation-
hips, might also benefit from such fusion image guidance.
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